Friday, February 07, 2025 12:57:29 AM
Yea, I agree.
Assuming an inspection delay is true, and there's a 2nd CHM meeting at the end of February and it takes 2-3 weeks for approval news after, that lands us at the end of March.
December 21st, 2023 to March 31st, 2025: 466 Days
Look, I understand the MHRA had a considerable backlog, and many factors may not be in NWBO's control, but this is getting ridiculous with the absolute snail's pace this is going. The share price being at $0.27 is not helping either. LP really needs to hit it out of the park if/when approval does come with something SUBSTANTIAL. We need to get out of this rut that the company was forced into.
Just venting is all.
Assuming an inspection delay is true, and there's a 2nd CHM meeting at the end of February and it takes 2-3 weeks for approval news after, that lands us at the end of March.
December 21st, 2023 to March 31st, 2025: 466 Days
Look, I understand the MHRA had a considerable backlog, and many factors may not be in NWBO's control, but this is getting ridiculous with the absolute snail's pace this is going. The share price being at $0.27 is not helping either. LP really needs to hit it out of the park if/when approval does come with something SUBSTANTIAL. We need to get out of this rut that the company was forced into.
Just venting is all.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
